PPG (PPG) Q3 2026 Earnings Call Transcript

PPG reported record Q3 adjusted EPS of $2.25, up 6% year over year, on net sales of $4.353B, up 7%, and 5% organic sales growth; it outpaced the coatings industry by 300 bps. Management raised the midpoint of full-year adjusted EPS guidance to a $7.90–$8.10 range and expects Q4 organic sales growth in the low-single-digit range, while forecasting high-single-digit COGS inflation. Aerospace sales are expected to exceed $2B for the year, and the company repurchased $150M of shares in Q3; industrial coatings margins fell 260 bps to 14.4% as inflation outpaced index-based pricing, while management cited weaker China auto-build projections and uncertainty in Europe as risks.

Analysis

The quality of PPG’s growth matters more than the headline beat: differentiated aerospace, refinish normalization and packaging share gains are cushioning weak construction confidence and lower China auto builds. That mix supports resilience, but it also raises the bar for the weaker industrial segment, where index-contract timing—not just demand—remains the near-term earnings swing factor. The key potential upside is a lagged price reset in industrial coatings during Q1–Q2 2027; this is not yet a reliable price-cost tailwind while the raw-material basket is still rising. Watch realized pricing versus input costs by segment, not enterprise neutrality alone.

Near term, the raised annual outlook and margin execution are supportive, but Q4 deceleration, Europe uncertainty and China production cuts argue against extrapolating Q3 growth. Mexico’s currency contribution is a separate quality check: architectural margins should be assessed excluding that benefit. Over 6–18 months, European plant closures could improve the architectural cost base, while aerospace capacity spending creates execution and utilization risk if deliveries or customer demand slip. The announced aerospace backlog is supportive, but does not eliminate those risks.

Contrarian view: the market may focus on record earnings and overlook how much of the next leg depends on pricing catch-up and restructuring execution. Conversely, treating Q4’s slower growth as a turn in the cycle may understate the resilience of aerospace and packaging. Competitive disruption from the pending Axalta merger is only a watch item; management reported no meaningful change in market behavior so far, so it does not yet support a relative-value position.

Key Decisions for Investors

• Do not chase the earnings strength at the open; consider a staged PPG long on weakness, with the thesis tied to continued organic growth and margin expansion rather than a broad end-market recovery.
• Use Q1–Q2 2027 as the key price-cost catalyst window. Add only if subsequent reporting shows industrial segment margin compression moderating as index-based pricing catches up; cut or reassess if raw-material inflation continues to outpace realized pricing.
• Track architectural EBITDA margin excluding the disclosed Mexico peso benefit and monitor delivery of the European plant closures. Failure to sustain the company’s stated 20%-plus architectural margin ambition or slippage in restructuring benefits would weaken the margin-expansion thesis.
• Keep aerospace capacity utilization, backlog conversion, China auto builds and European demand on the risk dashboard. A deterioration in aerospace growth or a broader volume setback would falsify the view that differentiated businesses can offset cyclical weakness.